JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

JPM

242.09

-0.08%↓

AXP

264.69

+0.02%↑

RY

116.82

+0.22%↑

MMC

215.29

-0.92%↓

TD

61.92

+0.15%↑

Search

KKR & Co LP

Open

SectorFinanciën

113.23 0.72

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

111.62

Max

114.01

Belangrijke statistieken

By Trading Economics

Inkomsten

784M

1.4B

Verkoop

-1.5B

3.2B

K/W

Sectorgemiddelde

29.863

20.525

EPS

1.32

Dividendrendement

0.71

Winstmarge

43.254

Werknemers

4,834

EBITDA

45M

2.5B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+31.54% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.71%

4.36%

Volgende Winsten

1 mei 2025

Volgende Ex Dividend datum

12 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-26B

95B

Vorige openingsprijs

112.51

Vorige sluitingsprijs

113.23

Technische score

By Trading Central

Vertrouwen

Very Strong Bullish Evidence

KKR & Co LP Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 apr 2025, 06:50 UTC

Acquisities, Fusies, Overnames

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

14 apr 2025, 11:46 UTC

Acquisities, Fusies, Overnames

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1 Billion Deal

9 apr 2025, 10:24 UTC

Acquisities, Fusies, Overnames

EQT to Sell Karo Healthcare to KKR

9 apr 2025, 07:09 UTC

Acquisities, Fusies, Overnames

Assura Accepts $2 Billion Takeover Offer From KKR Consortium

9 apr 2025, 06:02 UTC

Acquisities, Fusies, Overnames

KKR Nears $2.85 Billion Deal With EQT For E45 Maker Karo Healthcare, FT Reports, Citing Sources

7 apr 2025, 14:42 UTC

Acquisities, Fusies, Overnames

Assura Agrees to Primary Health Properties Bid Deadline Extension

4 apr 2025, 10:15 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

4 apr 2025, 09:39 UTC

Acquisities, Fusies, Overnames

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

3 apr 2025, 14:57 UTC

Acquisities, Fusies, Overnames

Primary Health Proposes $1.95 Billion Bid for Assura -- Update

3 apr 2025, 07:17 UTC

Acquisities, Fusies, Overnames

Primary Health Proposes $1.95 Billion Bid for Assura

22 apr 2025, 06:04 UTC

Acquisities, Fusies, Overnames

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22 apr 2025, 06:03 UTC

Acquisities, Fusies, Overnames

KKR: Biotage Board Recommends Shareholders Accept Offer

22 apr 2025, 06:02 UTC

Acquisities, Fusies, Overnames

KKR: Offer Values Biotage at SEK11.61B

22 apr 2025, 06:02 UTC

Acquisities, Fusies, Overnames

KKR Makes SEK145 a Share Bid For Biotage

18 apr 2025, 00:00 UTC

Top Nieuws

Private Equity World Engulfed by Perfect Storm -- WSJ

14 apr 2025, 11:31 UTC

Top Nieuws
Acquisities, Fusies, Overnames

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1B Deal

14 apr 2025, 11:02 UTC

Acquisities, Fusies, Overnames

KKR: Making OSTTRA Investment Primarily Through North America Private-Equity Strategy >KKR

14 apr 2025, 11:01 UTC

Acquisities, Fusies, Overnames

S&P Global, CME to Divide Sale Proceeds Evenly Pursuant to 50/50 Joint Venture >SPGI CME

14 apr 2025, 11:00 UTC

Acquisities, Fusies, Overnames

S&P Global, CME Group to Sell OSTTRA to KKR for $3.1 Billion >SPGI CME KKR

14 apr 2025, 11:00 UTC

Acquisities, Fusies, Overnames

S&P Global and CME Group to Sell OSTTRA to KKR for $3.1 Billion

11 apr 2025, 11:56 UTC

Acquisities, Fusies, Overnames

KKR Now Owns 30% of Enilive

11 apr 2025, 11:55 UTC

Acquisities, Fusies, Overnames

KKR Completes Acquisition of Additional Stake in Enilive

9 apr 2025, 09:51 UTC

Acquisities, Fusies, Overnames

EQT to Sell Karo Healthcare to KKR for an Undisclosed Amount

9 apr 2025, 09:32 UTC

Acquisities, Fusies, Overnames

EQT: Transaction Expected to Close in Coming Months

9 apr 2025, 09:31 UTC

Acquisities, Fusies, Overnames

EQT to Sell Karo Healthcare to KKR

3 apr 2025, 08:17 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Primary Health Properties' Lower Bid for Assura Is a Calculated Risk -- Market Talk

28 mrt 2025, 09:34 UTC

Acquisities, Fusies, Overnames

Topcon: Tender Offer Expected to Start Around End-July >7732.TO

28 mrt 2025, 09:33 UTC

Acquisities, Fusies, Overnames

Topcon: CEO Takashi Eto Also Plans to Participate in Tender Offer, Make Reinvestment After Completion of Offer >7732.TO

28 mrt 2025, 09:31 UTC

Acquisities, Fusies, Overnames

Topcon: JICC Plans to Indirectly Hold Voting Rights in Topcon >7732.TO

28 mrt 2025, 09:31 UTC

Acquisities, Fusies, Overnames

Topcon: KKR Plans to Indirectly Hold Majority Interest in Topcon >7732.TO

Peer Vergelijking

Prijswijziging

KKR & Co LP Prognose

Koersdoel

By TipRanks

31.54% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 140.5 USD  31.54%

Hoogste 194 USD

Laagste 114 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor KKR & Co LP - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

12 ratings

11

Buy

1

Hold

0

Sell

Technische score

By Trading Central

101.87 / N/ASteun & Weerstand

Korte Termijn

Very Strong Bullish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Weak Bearish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over KKR & Co LP

KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market, and middle market investments. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, information technology infrastructure, financial technology, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy. In energy and infrastructure, it focuses on the upstream oil and gas and equipment, minerals and royalties and services verticals. In real estate, the firm seeks to invest in private and public real estate securities including property-level equity, debt and special situations transactions and businesses with significant real estate holdings, and oil and natural gas properties. The firm also invests in asset services sector that encompasses a broad array of B2B, B2C and B2G services verticals including asset-based, transport, logistics, leisure/hospitality, resource and utility support, infra-like, mission-critical, and environmental services. Within Americas, the firm prefers to invest in consumer products; chemicals, metals and m